• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » etrials 2nd Quarter Earnings Reflect Ongoing Financial Woes

etrials 2nd Quarter Earnings Reflect Ongoing Financial Woes

August 15, 2008
CenterWatch Staff

Just a month after etrials lost yet another key executive, the eClinical company released 2nd quarter numbers that illustrate the company’s ongoing struggles.

In the past few months, etrials has lost its chief executive officer, chief financial officer, and chief operating officer (whose position was eliminated). The Morrisville, N.C.-based company’s net loss for that same period was $2.2 million, versus a net loss of $1.3 million in the second quarter of 2007.

The gloomy earnings report comes despite a 12-month effort to embark on a “major transformation of its offerings and capabilities,” according to Robert Brill, etrials’ board chairman.

“We acknowledge that the company’s quarterly losses are unacceptable,” Brill said in this week’s investor call.

Interim CEO Chuck Piccirillo remains positive about etrials future, saying he expects revenue in the second half of 2008 to be equal to or slightly higher than the first half of the year.

“Our increase in backlog, bookings and awards are all early indicators that our news sales organization and selling strategies are beginning to take effect,” Piccirillo said in a company release. “Our strategy of aligning integrated solutions with customer needs is positioning etrials to capture an increasing share of the growing demand for eClinical solutions, particularly in the mid-tier market.”

Upcoming Events

  • 15Apr

    Five Telltale Signs You’re Ready for an Electronic TMF System

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

  • 06May

    The World of Post-COVID-19 Clinical Trials: How to Prepare for What’s Coming Next

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • Clinical-Trial-Brainstorming

    FDA, Industry Tackle Problem of Including Older Adults in Trials

  • ClinicalTrialNetwork-360x240.png

    National Community-Based Research Network Would Improve Reach of Trials

  • Bottleneck-360x240.png

    Sites Face Trials Bottleneck After Pandemic, But Also Opportunities

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Genetic Research and IBC Oversight Requirements

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing